Clinerion Upgrades its Website with Realtime Statistics from Patient Network Explorer and a Dynamic Map Searchable for Disease Indications Across its Global Patient Network
Clinerion has added a live heatmap to its homepage indicating prevalence of searchable disease indications by ICD10 code according to the global patient network in its Patient Network Explorer. Real-time statistics including the number of countries, sites and patients from Clinerion’s international network of partner hospitals are also now displayed.
Visitors to Clinerion’s website may now see a dynamic visual representation of its patient network on a map. The map shows locations, by country, and numbers of patients. When searched for a disease indication, the map shows a heatmap representation of the prevalence of the searched term, including partial matches. The user can then select a particular term to see its prevalence displayed on the map. This heatmap is linked directly to Clinerion’s Patient Network Explorer platform and shows live data from Clinerion’s international network of partner hospitals.
Alongside the map, visitors can also see the current global coverage of Patient Network Explorer, in terms of numbers of patients, sites and countries. These metrics reflect the current state of data on Clinerion’s network of partner hospitals and other data partners.
Patient Network Explorer integrates anonymised patient electronic health record data from Clinerion’s international network of partner hospitals and other data partners without compromising patient privacy. Patient Network Explorer is a hybrid cloud- and federated-server system that allows interoperable query of all partner databases instantaneously, at the same time, and in real-time. Patient Network Explorer leverages patient electronic health record data to offer data intelligence for drug development and bringing innovative drugs to patients earlier.
For clinical research, Patient Network Explorer improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. For real-world evidence, Patient Network Explorer offers access to real-world data queried directly from anonymised patient data, allowing detailed data analysis of patient journeys and outcomes.
“Our international hospital network is rapidly expanding, and Clinerion’s offering is dynamically evolving,” says Ian Rentsch, CEO of Clinerion. “The heatmap and homepage statistics help our visitors to keep track of our coverage.“
Caption: Clinerion’s homepage now contains real-time statistics from its Patient Network Explorer and a dynamic map which can be searched live for disease indications across its global patient network.
Caption: The map dynamically shows live data on locations and numbers of patients according to the prevalence of a searched disease indication. This data is taken in real-time from the international network of partner hospitals on Clinerion’s Patient Network Explorer platform.
About Clinerion
Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: www.clinerion.com
Clinerion’s Patient Network Explorer: www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer
For more information, please contact:
Le Vin Chin
Director, Head of Marketing & Communications
Clinerion Ltd
Elisabethenanlage 11, 4051 Basel, Switzerland
Tel.: +41 61 865 60 54
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
